Cv Sciences Inc (CVSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CVSI | BXRX | RGLS | ||
| Company | Cv Sciences Inc | Baudax Bio Inc | Regulus Therapeutics | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 0.6066 | 1.4010 | 1.7800 | ||
| High | 0.6148 | 1.4500 | 1.8000 | ||
| Low | 0.5500 | 1.2100 | 1.4700 | ||
| Last | 0.5777 | 1.4300 | 1.6050 | ||
| Change | -0.0373 | -0.0800 | +0.0550 | ||
| % Change | -6.07% | -5.30% | +3.55% | ||
| Volume | 553,359 | 4,565,978 | 2,685,415 | ||
| 20-Day Average Volume | 1,224,778 | 6,585,165 | 1,502,794 | ||
| Previous Close | 0.6150 | 1.5100 | 1.5500 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 0.5704 | 1.2817 | 1.2840 | ||
| 20-Day Raw Stochastic | 46.00% | 43.93% | 61.76% | ||
| 20-Day Relative Strength | 51.60% | 52.51% | 67.27% | ||
| Weighted Alpha | -70.87 | -58.80 | +52.31 | ||
| Today's Opinion | 40% Buy | 40% Sell | 100% Buy | ||
| Previous Opinion | 40% Buy | 40% Sell | 100% Buy | ||
| Last Month's Opinion | 72% Sell | 100% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.50% since 01/20/21 | -19.71% since 01/20/21 | +29.66% since 01/20/21 | ||
| Low | 0.5500 on 01/27/21 | 1.2100 on 01/27/21 | 1.1605 on 01/21/21 | ||
| High | 0.7100 on 01/22/21 | 1.8500 on 01/21/21 | 1.7900 on 01/27/21 | ||
| 1-Month | |||||
| %Chg | +19.94% since 12/24/20 | +30.00% since 12/24/20 | +9.29% since 12/24/20 | ||
| Low | 0.4600 on 01/04/21 | 0.9850 on 01/04/21 | 1.1100 on 01/13/21 | ||
| High | 0.7100 on 01/22/21 | 1.8500 on 01/21/21 | 1.7900 on 01/27/21 | ||
| 3-Month | |||||
| %Chg | +19.79% since 10/27/20 | +12.81% since 10/27/20 | +196.17% since 10/27/20 | ||
| Low | 0.3960 on 11/25/20 | 0.9700 on 12/22/20 | 0.4500 on 11/06/20 | ||
| High | 0.7400 on 11/30/20 | 1.8500 on 01/21/21 | 1.7900 on 01/27/21 | ||
| 6-Month | |||||
| %Chg | +0.88% since 07/27/20 | -57.74% since 07/27/20 | +86.59% since 07/27/20 | ||
| Low | 0.3960 on 11/25/20 | 0.9700 on 12/22/20 | 0.4222 on 09/08/20 | ||
| High | 0.8900 on 08/05/20 | 3.9400 on 09/02/20 | 1.7900 on 01/27/21 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 62,880 | 64,383 | 60,703 | ||
| Shares Outstanding, K | 102,244 | 42,638 | 39,163 | ||
| Annual Sales | 53,700,000 | 0 | 6,830,000 | ||
| Annual Net Income | -16,610,000 | -32,560,000 | -18,590,000 | ||
| Last Quarter Sales | 5,560,000 | 70,000 | 5,000,000 | ||
| Last Quarter Net Income | -3,160,000 | 11,690,000 | -1,520,000 | ||
| 60-Month Beta | 0.45 | 2.56 | 2.41 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | N/A | ||
| Latest Earnings Date | 03/15/21 | 02/11/21 | 03/11/21 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||
